US3221015A - 3,8-diazabicyclo-[3,2,1]-octanes and process for preparing same - Google Patents

3,8-diazabicyclo-[3,2,1]-octanes and process for preparing same Download PDF

Info

Publication number
US3221015A
US3221015A US104016A US10401661A US3221015A US 3221015 A US3221015 A US 3221015A US 104016 A US104016 A US 104016A US 10401661 A US10401661 A US 10401661A US 3221015 A US3221015 A US 3221015A
Authority
US
United States
Prior art keywords
diazabicyclo
octane
percent
solution
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US104016A
Other languages
English (en)
Inventor
Cignarella Giorgio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5642/60A external-priority patent/GB937183A/en
Application filed by Lepetit SpA filed Critical Lepetit SpA
Application granted granted Critical
Publication of US3221015A publication Critical patent/US3221015A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C49/00Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor
    • B29C49/18Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor using several blowing steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C49/00Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor
    • B29C49/02Combined blow-moulding and manufacture of the preform or the parison
    • B29C49/04Extrusion blow-moulding

Definitions

  • This invention relates to new heterocyclic compounds and process for preparing the same.
  • the compounds of the invention are 3,8-diazabicyclo-[3,2,1]-octanes of the formula:
  • R represents hydrogen, lower alkyl, aryl and aralkyl, R represents hydrogen, or methyl.
  • 3-benzyl-8-methyl- 3-8-diazabicyclo-[3,2,1]-octane methiodide has analgetic properties and increases in mice the stimulus threshold (expressed in mm. Hg as pressure applied to the excited member, according to the Randall and Selitto procedure) of +23 at the doses of 2 mg./kg. and of +48 at 5 mg./kg.
  • 3-cinnamyl-8- methyl-3 ,8-diazabicyclo- 3 ,2,1]-octane increases urinary excretion by about 170 percent at 10 mg./ kg. and sodium excretion by over 120 percent at 10 mg./kg. and by 180 percent at 25 mg./ kg. in mice.
  • the process of the invention consists in adding an ether solution of 3,8-diazabicyclo-[3,2,l]-octane-2,4-dione of the formula:
  • the internal anhydride of the carbobenzoxypyrrolidine- 2,5-dicarboxylic acid (I) is prepared by hydrogenating 2,5-dicarbethoxy-N-benzylpyrrolidine under a pressure of about 20 atmospheres, using palladium on charcoal catalyst, hydrolysing the 2,5-dicarbethoxypyrrolidine (VI) thus obtained by refluxing the aqueous suspension separating the acid (VII) by concentrating the clear resulting solution and then treating it with the appropriate reagent, such as benzyl chlorocarbonate.
  • Pyrrolidine-2,5-a'icarboxylic acid A suspension of 200 g. of 2,5-dicarbethoxypyrrolidine in 8 1. H O is refluxed for 25-30 hours.
  • N-carbobenzoxypyrrolidine-2,5-dicarb0xylic acid To a solution of 67 g. of pyrrolidine 2,5-dicarboxylic acid in 420 ml. 2 N NaOH, cooled to 8-10 C. are added with vigorous stirring 73 g. of benzyl chlorocarbonate together with 210 ml. 2 N NaOH over a period of 30 minutes. The solution is stirred for 2 hours at room temperature, then it is extracted with ethyl ether and the aqueous phase is acidified with concentrated HCl. An oil separates which is extracted with ethyl ether and the evaporated ether extract gives an oil that solidifies in vacuo in a short time. Yield 86.5 g. (64.5%), M.P. 125- 127 C.
  • N -car,bobenz0xy pyrrolidine-2,5 -a'icarb0xy lic acid anhydride A solution of 79 g. of N-carbobenzoxypyrrolidine-Z,5- dicarboxylic acid in 360 ml. acetic anhydride is refluxed for 1 hour, then it is evaporated to dryness; the residue is heated for '1 hour at 14 C. under 1 mm. pressure. The residue is then cooled, taken up in ml. warm ethyl ether which dissolves the coloured impurities and the anhydride is collected by filtering in vacuo. Yield 58.1 g. (78% M.P. 166-168" C.
  • the resulting crude monoamide is refluxed with 5 portions of its weight of acetic anhydride for 1 hour.
  • the mixture acetic acid-acetic anhydride is distilled in vacuo and heated for :1 hour at 130-140 C. under 1 anrn. pressure till the reaction is complete.
  • the residue is then taken up with 300 ml. ethyl ether and the insoluble portion is removed. After drying over Na SO the solvent is removed and the product is purified by distillation. Yield 1'8 g. (66%), M.P. C.
  • EXAMPLE 2 3-methyl-8-carbobenz0xy-3,8-diazabicycl0- [3,2,1 -0ctane- 2,4-dione
  • S-dicarboxylic acid anhydride in 300 ml. anhydrous benzol 3.42 g. of methylamine are added with cooling.
  • the solution is refluxed for 30 minutes, the solvent is removed in vacuo and the obtained crude monoamide is refiuxed with 5 portions of its weight of acetic anhydride for 1 hour.
  • the main solvent is distilled in vacuo and the reaction is completed by heating at l40 C. for 1 hour under 1 mm. pressure.
  • EXAMPLE 10 2 -benzy lcarbamyl-S -carbeth oxy-pyrrolidine A mixture of 21.5 g. of 2,5-dicarbethoxypyrrolidine and 11.8 g. of benzylamine in 50 ml. of anhydrous xylene is refluxed for 24 hrs; the main part of the organic solvent is removed, the 2,S-dibenzylcarbamyl-pyrrolidine that precipitates from the concentrated solution is filtered off, and after removing the solvent the residue is distilled in vacuo. Yield 20.2 g. (72.5%),. B.P. 178180 C./0.3 mm. An elemental analysis gave C, 65,38 percent; H, 7.19 percent; N, 10.33 percent. Calcd. for C H N O C, 65.21 percent; H, 7.24 percent; N, 10.14 percent.
  • a compound of the class consisting of a 3,8-diazabicyclo-[3,2,1]-octane of the formula:
  • R is a member of the class consisting of hydrogen, lower alkyl, phenyl, cinnamyl, benzyl and chlorobenzhydryl, R is a member of the class consisting of hydrogen and methyl and its quaternary non-toxic addition salts.
  • X is a member of the class consisting of hydrogen and carbobenzoxy and R is a member of the class consisting of hydrogen, lower alkyl, phenyl, cinnamyl, benzyl and chlorobenzhydryl, which comprises reacting a compound of the formula:
  • CHzGH-C O wherein X has the above significance, with an excess of an amine of the formula NH R wherein R has the above significance, in an inert anhydrous organic solvent and refluxing the obtained monoamide with acetic anhydride.
  • CH2-CHCO 1TTX III-R CHzCH-CO wherein X is a member of the class. consisting of hydrogen and carbobenzoxy and R is a member of the class consisting of hydrogen, lower alkyl, phenyl, cinnamyl, benzyl and chlorobenzhydryl.
  • NICHOLAS S. RIZZO Primary Examiner.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
US104016A 1960-02-17 1961-04-19 3,8-diazabicyclo-[3,2,1]-octanes and process for preparing same Expired - Lifetime US3221015A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5642/60A GB937183A (en) 1960-02-17 1960-02-17 3,8-diazabicyclo-[3,2,1]-octanes
GB2069560 1960-06-13

Publications (1)

Publication Number Publication Date
US3221015A true US3221015A (en) 1965-11-30

Family

ID=26240042

Family Applications (1)

Application Number Title Priority Date Filing Date
US104016A Expired - Lifetime US3221015A (en) 1960-02-17 1961-04-19 3,8-diazabicyclo-[3,2,1]-octanes and process for preparing same

Country Status (3)

Country Link
US (1) US3221015A (de)
CH (2) CH404678A (de)
DE (2) DE1445094A1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266576A2 (de) * 1986-10-08 1988-05-11 Bristol-Myers Squibb Company 1-Tert-alkyl-substituierte Naphthyridin- und Chinolincarbonsäure als antibakterielle Mittel
EP0288519A4 (en) * 1986-10-08 1992-04-15 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine- and quinoline-carboxylic acid antibacterial agents
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266576A2 (de) * 1986-10-08 1988-05-11 Bristol-Myers Squibb Company 1-Tert-alkyl-substituierte Naphthyridin- und Chinolincarbonsäure als antibakterielle Mittel
EP0266576A3 (de) * 1986-10-08 1989-03-22 Bristol-Myers Squibb Company 1-Tert-alkyl-substituierte Naphthyridin- und Chinolincarbonsäure als antibakterielle Mittel
EP0288519A4 (en) * 1986-10-08 1992-04-15 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine- and quinoline-carboxylic acid antibacterial agents
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
US5385906A (en) * 1988-12-06 1995-01-31 The Upjohn Company Antibacterial quinolone compounds

Also Published As

Publication number Publication date
DE1200316B (de) 1965-09-09
CH408036A (de) 1966-02-28
DE1445094A1 (de) 1968-11-21
CH404678A (de) 1965-12-31

Similar Documents

Publication Publication Date Title
US3155669A (en) 2, 4, 8-triaza-spiro (4, 5) dec-2-enes
DE3789039T2 (de) Verbrückte bicyclische N-heterocyclische Verbindungen.
US3155670A (en) 1-oxo-2, 4, 8, triaza-spiro (4, 5) decanes
US3161644A (en) 1-benzyl-4-substituted piperidines
US3703529A (en) Nitrogen-containing tricyclic compounds
AU624161B2 (en) New substituted 1, 7-annelated 1h-indazoles
HU213099B (en) Process for producing 2,8-diazabicyclo[4.3.0]nonan
US4985420A (en) 1,7-annelated indolecarboxylic acid esters and -amides
US3830823A (en) Process for the preparation of deethyleburnamonines
US4220774A (en) Vincadifformine synthesis process
CIGNARELLA et al. Bicyclic homologs of piperazine. II. Synthesis of 3, 8-diazabicyclo [3.2. 1] octane. New synthesis of 8-methyl-3, 8-diazabicyclo [3.2. 1] octane
US3221015A (en) 3,8-diazabicyclo-[3,2,1]-octanes and process for preparing same
Sulkowski et al. 2, 5-Benzodiazocines and intermediates
Blicke et al. Antispasmodics. XIX. Esters of 1-methyl-2-(hydroxymethyl)-pyrrolidine and 1-methyl-2-(hydroxymethyl)-piperidine
Leonard et al. Rearrangement of α-Aminoketones During Clemmensen Reduction. XI. The Reduction of Atom-bridged Bicyclic α-Aminoketones1, 2
US3462451A (en) 2,3-bis(alkoxyphenyl)pyrroles
Despinoy et al. Hydrogenation of pyrrolizin-3-ones; new routes to pyrrolizidines
GB1563745A (en) Methanobenzazocine derivatives and process for preparing the same
Stefancich et al. Research on nitrogen heterocyclic compounds. XII. Synthesis of 5H‐pyrrolo [1, 2‐b][2] benzazepine derivatives
US3282942A (en) Substituted cycloalkanoindoles
EP0110496B1 (de) Keto-Zwischenprodukte, ihre Anwendung und Herstellung
Southwick et al. 1-Carbamoyl-and 1-aminomethyl-1, 4-dihydropyrrolo [3, 4-b] indole derivatives. Indole formation by fragmentation of strain-barrier stabilized 2-aminoindoline derivatives
US3573323A (en) 1,2,3,4,5,10-hexahydroazepino(2,3-b)indoles
SU1017167A3 (ru) Способ получени @ -5-ацетамидо-4,5,6,7-тетрагидро-2н-бензо/с/пиррола
CA1281322C (en) Substituted pyrimidoindoles